Lawsuit for Damages Against Biovill Withdrawn by Plaintiff
-
Lawsuit for damages filed by BioVill Co., Ltd. was concluded by plaintiff's withdrawal
-
No judgment amount, no impact on equity (approx. KRW 121 billion)
-
Confirmed withdrawal on April 30, 2026 at Seoul Eastern District Court
KOSPI Filing Information
-
Filing: Judgment/Decision on Lawsuits, etc. (Claims of a Certain Amount or More)
-
Company: Samsung Pharmaceutical (001360)
-
Submission: Samsung Pharmaceutical Co., Ltd.
-
Receipt: 05-08-2026
-
Under KRX KOSPI Market Division